Keywords
Anti-tumor immunity
Biomarkers
bladder
bladder cancer
cancer
cancer immune landscape
cancer immunity
Cancer immunotherapy
Complex I
Complex III
cost
Epigenetics
FGFR3-targeted therapy
germline genetics
GWAS
Hepatosteatosis
heritability
iATLAS
Immune checkpoint
Immune checkpoint inhibitors
Immune subtypes
Immunotherapy
Innate immune activation
in silico biology
Ipilimumab
Mathematical biosciences
mathematical model
methyltransferase
Mitochondria
Nivolumab
PD-1
Pembrolizumab
rare variant analysis
Reactive oxygen species
S1QEL
S3QEL
STING agonist
Succinate dehydrogenase
systemic
Systems biology
TCGA
Tumor microenvironment
urothelial
Urothelial cancer
value